Financials & Filings Show all 2023 Second Quarter Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2023 and Provides Business Update Form 10-Q Annual Reports Title View Add Files 2022 Form 10-K 2.1 MB Add Files 2022 Form 10-K 2.1 MB Add Files 2021 Form 10-K 946.2 KB Add Files 2021 Form 10-K 946.2 KB Proxy Statements Filing date View Oct 17, 2022 View HTML 0001140361-22-037309.pdf 0001140361-22-037309.xls Oct 17, 2022 View HTML 0001140361-22-037310.pdf 0001140361-22-037310.xls Form 10-K Filing date View Mar 30, 2023 View HTML 0001140361-23-014658.pdf 0001140361-23-014658.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Mar 31, 2022 View HTML 0001140361-22-012058.pdf 0001140361-22-012058.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Form 10-Q Filing date View Aug 14, 2023 View HTML 0001140361-23-039411.pdf 0001140361-23-039411.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA May 15, 2023 View HTML 0001140361-23-024499.pdf 0001140361-23-024499.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA